BioRestorative Therapies, Inc. - 8-K Filing

BioRestorative Therapies' VP of R&D resigns citing 'Good Reason,' triggering potential $1.29M severance under disputed employment agreement (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $BRTX

Read the full article at SEC EDGAR

More Regulatory news